Screener
Xeris Biopharma Holdings, Inc. XERS Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
FAQ
- What is Xeris Biopharma Holdings, Inc.'s net income?
- Xeris Biopharma Holdings, Inc. (XERS) reported net income of -$31.1M in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s net income changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s net income decreased by 1513.1% year-over-year, from -$1.93M to -$31.1M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s net income?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s net income has grown at a -74.1% compound annual growth rate (CAGR), from -$122.73M to $554K.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Xeris Biopharma Holdings, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude